Participants indicated the following priorities:
| |
|
Rating for priorities |
Topic |
n |
4 = very high |
3 = high |
2 = low |
1 = very low |
1. Public financing |
| |
1.1 Health and drug financing indicators |
10 |
7 |
3 |
0 |
0 |
| |
1.2 Experiences in increasing government health and drug budgets |
10 |
5 |
3 |
2 |
0 |
2. Cost-sharing for health and drugs |
| |
2.1 Policies and guidelines |
9 |
5 |
4 |
0 |
0 |
| |
2.2 Report of experiences/lessons from cost-sharing systems |
7 |
3 |
4 |
0 |
0 |
3. Insurance for health and drugs |
| |
3.1 Alternative insurance systems |
8 |
2 |
6 |
0 |
0 |
| |
3.2 Mechanisms for providing drugs through insurance |
6 |
3 |
2 |
1 |
0 |
4. The use of international loans in the pharmaceutical sector |
6 |
3 |
2 |
1 |
0 |
5. Drug pricing policies and mechanisms |
| |
5.1 Control of drug manufacturers' prices |
8 |
5 |
0 |
3 |
0 |
| |
5.2 Distribution mark-ups (wholesale and retail margins) |
8 |
2 |
3 |
3 |
0 |
| |
5.3 Use of generic drugs to promote competition |
8 |
3 |
4 |
1 |
0 |
| |
5.4 Cost containment in the drug sector |
8 |
3 |
5 |
0 |
0 |
6. Financing mechanisms to improve: |
| |
6.1 Drug selection |
9 |
3 |
5 |
1 |
0 |
| |
6.2 Drug supply |
7 |
3 |
1 |
3 |
0 |
| |
6.3 Drug quality assurance |
8 |
2 |
6 |
0 |
0 |
| |
6.4 Drug distribution |
6 |
3 |
3 |
0 |
0 |
| |
6.5 Rational use of drugs |
7 |
4 |
3 |
0 |
0 |
7. Health reform and global change |
| |
7.1 Drugs and health sector reform |
7 |
4 |
3 |
0 |
0 |
| |
7.2 Impact of globalization WTO/TRIPS on drugs |
8 |
3 |
4 |
1 |
0 |
| |
7.3 Public-private roles in pharmaceutical sector |
8 |
6 |
2 |
0 |
0 |
Questions
1. For field visits, should there be:
⇒ more visits/different types of facilities (5)*
⇒ same number of visits (4)
⇒ no field visit (0)
(*) Number in brackets indicates the number of responses
2. For prepared presentations on specific topics, should there be:
⇒ more presentations (2)
⇒ same presentations (6)
⇒ fewer presentations (0)
3. For group discussions, should there be:
⇒ more time (5)
⇒ same amount of time (3)
⇒ less time (0)
4. Other comments:
⇒ More time for presentation and discussion, and for discussion on the field visits.
⇒ Participants should know what to prepare, etc. at least one month beforehand.
⇒ Health economics experts should be invited to the next meeting and presentation.
* * *
Loading...
